During development, dopaminergic neurons born in the substantia nigra extend their axons toward the striatum. However, the mechanisms by which the dopaminergic axons extend the striatum to innervate their targets remain unclear. We previously showed that paired-cultivation of mesencephalic cells containing dopaminergic neurons with striatal cells leads to the extension of dopaminergic neurites from the mesencephalic cell region to the striatal cell region. The present study shows that dopaminergic neurites extended along striatal neurons in the paired-cultures of mesencephalic cells with striatal cells. The extension of dopaminergic neurites was suppressed by the pharmacological inhibition of integrin α5β1. Using lentiviral vectors, short hairpin RNA (shRNA)-mediated knockdown of integrin α5 in dopaminergic neurons suppressed the neurite outgrowth to the striatal cell region. In contrast, the knockdown of integrin α5 in non-dopaminergic mesencephalic and striatal cells had no effect. Furthermore, overexpression of integrin α5 in dopaminergic neurons differentiated from embryonic stem cells enhanced their neurite outgrowth on striatal cells. These results indicate that integrin α5β1 expression on dopaminergic neurons plays an important role in the dopaminergic neurite outgrowth on striatal neurons. Dopaminergic neurons in the substantia nigra pars compacta project to the dorsolateral striatum, thus forming the nigrostriatal projection. In humans, a selective loss of this projection is a pathological hallmark of Parkinson disease (PD). Although the exact causes of neuronal loss remain unclear, the regeneration of this pathway shows great promise as a therapy for PD. Transplantation of fetal nigral dopamine neurons for PD patients gives rise to substantial symptomatic relief for a decade 1 , although it have been reported that dyskinesia occurs after transplantation 2 . Olanow et al. 3 suggest that it is likely that off-medication dyskinesia represent a variant of diphasic dyskinesia due to incomplete or aberrant reinnervation of the striatum. To successfully reestablish the lost nigrostriatal pathway, considerable knowledge regarding the axon guidance signals present in the extracellular milieu is required.
Dopaminergic neurons in the substantia nigra pars compacta project to the dorsolateral striatum, thus forming the nigrostriatal projection. In humans, a selective loss of this projection is a pathological hallmark of Parkinson disease (PD). Although the exact causes of neuronal loss remain unclear, the regeneration of this pathway shows great promise as a therapy for PD. Transplantation of fetal nigral dopamine neurons for PD patients gives rise to substantial symptomatic relief for a decade 1 , although it have been reported that dyskinesia occurs after transplantation 2 . Olanow et al. 3 suggest that it is likely that off-medication dyskinesia represent a variant of diphasic dyskinesia due to incomplete or aberrant reinnervation of the striatum. To successfully reestablish the lost nigrostriatal pathway, considerable knowledge regarding the axon guidance signals present in the extracellular milieu is required.
In rat and mouse embryos, dopaminergic axons, which begin their projection in a dorsal direction from the ventrocaudal region of the midbrain, are rostrally guided by Wnt5a and Semaphorin 3F as chemorepellants and Wnt7b as a chemoattractant [4] [5] [6] [7] . The dopaminergic axons rostrally elongate along the medial forebrain bundle as they move ventrally to the thalamus. Next, the axons are directed into the striatum via the repulsive effect of ephrin-A5 8 . Although a correlation between dopaminergic innervation and the striatal distribution of glycosaminoglycans during the early postnatal period has been suggested 9 , it remains unclear how the dopaminergic axons extend to the striatum in order to innervate their targets.
To address this issue, we previously reconstructed the dopaminergic innervation of striatal cells using dissociated primary cultures 10 . When mesencephalic cells containing dopaminergic neurons were adjacently paired-cultured with striatal cells, dopaminergic neurites extended from the mesencephalic cell region to the striatal cell region. In addition, this paired-cultivation enables the quantitative evaluation of dopaminergic neurite outgrowth to the striatal cell region. In the present study, we pharmacologically and genetically examined the precise mechanisms behind the dopaminergic neurite outgrowth on striatal neurons in the paired-cultures. Here, we show that integrin α 5β 1 expression on dopaminergic neurons is involved in the dopaminergic neurite outgrowth on striatal neurons. In addition, we investigated the neurite outgrowth of integrin α 5-overexpressing dopaminergic neurons derived from embryonic stem (ES) cells on striatal cultures.
Results
Dopaminergic neurite outgrowth on striatal neurons in paired-cultures of mesencephalic and striatal cells. Our previous study 10 demonstrated that dopaminergic neurites extended from the mesencephalic cell region to the striatal cell region after 10 days of paired-cultivation of mesencephalic and striatal cells (Fig. 1a) . We used fluorescence staining to clarify the pattern of dopaminergic neurite outgrowth to the striatal cell region. Nuclear staining with Hoechst 33258 in the striatal cell region revealed that striatal cells formed clusters after 10 days in culture. The clusters of striatal cells were surrounded by microtubule associated protein 2 (MAP2)-positive dendrites of striatal neurons, suggesting that striatal neurons tended to form clusters (Fig. 1b) . Phosphorylated neurofilaments (pNF)-positive axons of striatal neurons connected the clusters (Fig. 1c) . Importantly, tyrosine hydroxylase (TH)-positive dopaminergic neurites extended along the clusters of striatal neurons (Fig. 1b and c) . Glial fibrillary acidic protein (GFAP)-positive astrocytes were mainly localized to the striatal cell region outside of the clusters (Fig. 1c) . In our previous report 10 , synaptophysin was expressed at the growth cones of dopaminergic neurites which extended along the striatal neuronal clusters. To examine the involvement of striatal astrocytes in dopaminergic neurite outgrowth, mesencephalic cells were adjacently paired-cultured with striatal astrocytes for 10 days. The paired-cultivation with striatal astrocytes had no effect on dopaminergic neurite outgrowth (Fig. 1d) . To examine the involvement of humoral factors from striatal cells in dopaminergic neurite outgrowth, mesencephalic cells were cultured in striatal cell-conditioned medium (CM) for 10 days. The striatal CM had no effect on dopaminergic neurite outgrowth (Fig. 1e) . We previously reported that glial derived neurotrophic factor (GDNF) extended dopaminergic neurites beyond the mesencephalic cell region in mesencephalic cell cultures 10 . However, GDNF did not enhance dopaminergic neurite outgrowth to the striatal cell region in the paired-cultures of mesencephalic and striatal cells (Fig. 1f) , suggesting that the signaling of GDNF was saturated.
Inhibition of integrin α5β1 suppressed dopaminergic neurite outgrowth to the striatal cell region. Cell adhesion molecules, such as neural cell adhesion molecule (NCAM) and integrin, play important roles in the signaling of GDNF for dopaminergic neurite outgrowth [11] [12] [13] . The function-blocking antibody anti-NCAM (AB5032), which inhibited GDNF-induced dopaminergic neurite outgrowth (data not shown), had no effect on the dopaminergic neurite outgrowth to the striatal cell region in the paired-cultures of mesencephalic and striatal cells (Fig. 2a) . In contrast, the synthetic Arg-Gly-Asp-Ser (RGDS) peptide, an inhibitor of RGD-binding integrins, significantly suppressed neurite outgrowth, whereas treatment with a glutamic acid-substituted control peptide (RGES) showed no effect ( Fig. 2b and c) . To narrow down the candidates of integrin heterodimers, the effects of more selective blocking peptides were examined. ATN-161 (Ac-PHSCN-NH 2 ), which is derived from the synergy region of fibronectin, binds to both α 5β 1 and α Vβ 3 in vitro 14 . Cyclo(RGDfV), a cyclic pentapeptide containing the RGD sequence, is a selective α Vβ 3 antagonist 15 . A5-1 (VILVLF) is an antagonistic peptide against integrin α 5β 1 16 . ATN-161 and A5-1 significantly suppressed dopaminergic neurite outgrowth to the striatal cell region, whereas treatment with cyclo(RGDfV) had no effect (Fig. 2d-f) . To confirm the involvement of integrin α 5β 1, the effects of function-blocking antibodies were examined. Anti-integrin α 5 (HMa5-1) and anti-integrin β 1 (Ha2/5) antibodies have function-blocking properties 17, 18 . These antibodies significantly suppressed dopaminergic neurite outgrowth to the striatal cell region, whereas treatment with control IgG had no effect (Fig. 2g-i) .
Expression of integrin α5β1 in dopaminergic neurons. We examined the expression of integrin mRNA (integrin α 1, 2, 4, 5, 6, 7, 8, V, and β 1, 2, 3, 4, 5) in mesencephalic and striatal cultures. Whole-brain samples from adult rats were used as a positive control. Although there were differences in expression levels, all of the integrin mRNAs tested in this study were expressed, except for integrin β 4 in mesencephalic cultures and integrin α 2 in striatal cultures (Fig. 3a) . Integrin α 5 and β 1 were expressed in dopaminergic soma (Fig. 3b) . Furthermore, integrin α 5 and β 1 were intensely expressed in dopaminergic growth cones and varicosities (Fig. 3c) . The percentage of dopaminergic neurons expressing integrin α 5 and β 1 was 96.7 ± 1.9% and 93.3 ± 2.1%, respectively. To examine the involvement of integrin α 5β 1 in dopaminergic neurite outgrowth, the outside of the mesencephalic cell region was coated with extracellular matrix. Fibronectin is a glycoprotein that binds to integrin α 5β 1. The fibronectin coating outside of the mesencephalic cell region enhanced dopaminergic neurite outgrowth in mesencephalic cell cultures. Collagen and laminin are extracellular matrices that bind to integrin family members other than integrin α 5β 1. The collagen type I coating enhanced dopaminergic neurite outgrowth, whereas the no effect on dopaminergic neurite outgrowth. Control (Mes) group: mesencephalic cells were cultured alone for 10 days. Mes + Striatal astrocytes group: mesencephalic cells were paired-cultured with astrocytes derived from the striatum. Mes/St group: mesencephalic cells were paired-cultured with striatal cells. (e) Striatal CM did not affect dopaminergic neurite outgrowth. Mes + Striatal CM group: mesencephalic cells were cultured in CM prepared from striatal cultures. (f) GDNF did not enhance dopaminergic neurite outgrowth in paired-cultures of mesencephalic and striatal cells. Mesencephalic cells only or paired-cultures of mesencephalic and striatal cells were incubated in the presence or absence of GDNF (10 ng/mL) for 10 days. *p < 0.05 and ***p < 0.001 vs. control (Mes) group. n.s.: not significant. laminin coating did not (Fig. 3d) . A5-1 suppressed dopaminergic neurite outgrowth on fibronectin coating, but did not on collagen coating (Fig. 3e) .
Knockdown of integrin α5 in mesencephalic cells suppressed dopaminergic neurite outgrowth to the striatal cell region. Integrin α 5β 1 was expressed in both mesencephalic and striatal cultures. To clarify the involvement of integrin α 5β 1 expression on dopaminergic neurons in neurite outgrowth, we completed a lentiviral vector-mediated gene knockdown in mesencephalic cells. The silencing lentiviral vector constructs expressed both shRNA and Venus, which was as a marker gene (Fig. 4a) . To produce mesencephalic cell-specific knockdown, the lentiviral vectors were applied to the inside of the isolation wall containing mesencephalic cells. The isolation wall was removed the next day after the lentiviral vectors were washed out. After paired-cultivation with striatal cells for 5 days, Venus was preferentially expressed in mesencephalic cells (Fig. 4b) . Integrin α 5 shRNA selectively decreased the expression of endogenous integrin α 5 in mesencephalic cells and had no detectable effect on the expression in striatal cells (Fig. 4c) . After paired-cultivation with striatal cells for 10 days, immunocytochemistry was performed using anti-green fluorescent protein (GFP) (for Venus) and anti-TH antibodies. Both lentiviral vectors, which expressed either control shRNA or integrin α 5 shRNA, infected approximately 70% of the dopaminergic neurons ( Fig. 4d and e) . There was no difference in dopaminergic cell viability between vectors (Fig. 4f) . Figure 4g shows that distribution of dopaminergic growth cones from the borderline of the mesencephalic cell region. In cultures transfected with integrin α 5 shRNA, the number of Venus-positive dopaminergic growth cones was decreased away from the borderline. Thus, transfection of mesencephalic cells with integrin α 5 shRNA significantly suppressed Venus-positive dopaminergic neurite outgrowth to the striatal cell region (Fig. 4h) . There was no difference in the distribution of Venus-negative dopaminergic growth cones or the Venus-negative dopaminergic neurite outgrowth between control and integrin α 5 shRNA ( Fig. 4g and i) .
Knockdown of integrin α5 in striatal cells did not affect dopaminergic neurite outgrowth to the striatal cell region. To eliminate the possibility that integrin α 5β 1 expression in striatal cells is involved in dopaminergic neurite outgrowth, we selectively knock downed integrin α 5 in striatal cells. The lentiviral vectors were applied to the outside of the isolation wall containing striatal cells. After paired-cultivation with striatal cells for 5 days, Venus was preferentially expressed in striatal cells (Fig. 5a ). Integrin α 5 shRNA selectively decreased the expression of endogenous integrin α 5 in striatal cells and had no detectable effect in mesencephalic cells (Fig. 5b) . After paired-cultivation with striatal cells for 10 days, immunocytochemistry was performed using anti-TH antibodies. There was no difference in the distribution of dopaminergic growth cones or the dopaminergic neurite outgrowth between control and integrin α 5 shRNA ( Fig. 5c and d) .
Overexpression of integrin α5 in ES cell-derived dopaminergic neurons enhanced dopaminergic neurite outgrowth on striatal cultures. To confirm that integrin α 5β 1 expression on dopaminergic neurons participates in the neurite outgrowth on striatal neurons, we produced integrin α 5-overexpressing dopaminergic neurons from mouse ES cells. Full-length mouse integrin α 5 mRNA was isolated from the whole brain (Fig. 6a) . cDNA was incorporated into a bicistronic IRES-Venus expression lentiviral vector (LV-integrin α 5). The control vector (LV-control) consisted of the lentiviral backbone vector with the gene encoding Venus (Fig. 6b) . Mouse ES cells were transfected with these lentiviral vectors and cloned. We confirmed that undifferentiated ES cells transfected with the vectors expressed Venus (Fig. 6c) , LV-integrin α 5-transfected cells expressed integrin α 5, and undifferentiated ES cells did not express endogenous integrin α 5 (Fig. 6d) . The cloned ES cells were differentiated with the stromal cell-derived inducing activity method (SDIA method), by which mesencephalic dopaminergic neurons are induced 19 . We confirmed that the mesencephalic dopaminergic neuron markers Nurr1 and Ptx3 were induced in differentiated ES cells (Fig. 7a) . After differentiation, LV-integrin α 5-transfected cells expressed more integrin α 5 than LV-control-transfected cells (Fig. 7b) . Confocal microscopy showed that integrin α 5 was expressed at the plasma membrane of dopaminergic neurons differentiated from LV-control-transfected ES cells (Fig. 7c) . We confirmed that Venus expression in TH-positive neurons was maintained in both clones. Although more than 90% of colonies from LV-control-transfected cells were positive for neuron-specific β -III tubulin (TuJ1), more than 50% of colonies from LV-integrin α 5-transfected cells were negative for TuJ1 (Fig. 7d) . Flow cytometry demonstrated that the proportion of TuJ1-positive cells to total ES cells was significantly decreased by transfection with LV-integrin α 5 (Fig. 7e) . Regardless of the inefficiency of neural differentiation, immunofluorescence double-staining demonstrated that the proportion of TH-positive cells to TuJ1-positive cells was similar between LV-control-and LV-integrin α 5-transfected cells (Fig. 7f) . To examine the effect of integrin α 5 overexpression on dopaminergic neurite outgrowth, ES cell-derived dopaminergic neurons were replated on striatal cultures. We measured the total neurite lengths of Venus-positive dopaminergic neurons, and overexpression of integrin α 5 in dopaminergic neurons enhanced dopaminergic neurite outgrowth on striatal cultures (Fig. 7g) . In addition, the difference between LV-control-and LV-integrin α 5-transfected groups in dopaminergic neurite outgrowth expanded over time (1-3 days) (Fig. 7h) .
Discussion
In this study, we demonstrated that both pharmacological and genetic inhibition of integrin α 5β 1 suppressed the dopaminergic neurite outgrowth on striatal neurons. Furthermore, we showed that overexpression of integrin α 5 enhanced the neurite outgrowth of stem cell-derived dopaminergic neurons on striatal cells. These findings suggest that integrin α 5β 1 expression on dopaminergic neurons plays an important role in the dopaminergic neurite outgrowth on striatal neurons. Our previous report showed that in paired-cultivation conditions, dopaminergic axons prefer to extend to the striatal cell region rather than the spinal cell region 10 . Diffusible and/or membrane-bound factors derived from striatal cells enhance the maturation of dopaminergic neurons 20, 21 . In organotypic co-cultures of mesencephalic and striatal slices, the dopaminergic innervation of striatal slices is thought to result from adhesive interactions rather than from diffusible substances 22 . However, the axon-promoting factors involved in the dopaminergic neurite outgrowth on striatal neurons remain unknown. In paired-cultures with striatal cells, mesencephalic dopaminergic neurites extended along striatal neurons but not striatal astrocytes. This observation indicates that cell adhesion molecules between dopaminergic neurites and striatal neurons are important for the dopaminergic neurite outgrowth on striatal neurons. In contrast, CM derived from striatal cultures did not enhance dopaminergic neurite outgrowth, suggesting a small contribution of humoral factors to dopaminergic neurite outgrowth in our cultures. Because the concentration gradients of chemoattractants are important for the directional guidance of neurite outgrowth 23 , the exchange for CM derived from striatal cultures may be insufficient for the outward extension of dopaminergic neurites from the mesencephalic cell region. Interestingly, GDNF, which enhanced the outward extension of dopaminergic neurites from the mesencephalic cell region in mesencephalic cells only cultures, had no effect in paired-cultures of mesencephalic and striatal cells. This finding suggests that the interaction with striatal cells and GDNF share the same signaling pathway to promote the extension of dopaminergic neurites. We did not detect GDNF in the CM derived from paired-cultures of mesencephalic and striatal cells (data not shown).
GDNF exert its biological effects via GDNF family receptor-α 1 (GFRα 1) and RET tyrosine kinase 24 . In addition to RET, GFRα 1 directly interacts with NCAM and integrin β 1 12 . Notably, NCAM and integrin α V participate in GDNF-induced dopaminergic neurite outgrowth 11, 13 . Our pharmacological analysis revealed that integrin, rather than NCAM, participated in dopaminergic neurite outgrowth to the striatal cell region. Integrins are α β heterodimers, and to date, 8β subunits have been reported to assemble with 18α subunits to form 24 distinct integrins 25 . Among them, the RGD-binding integrins (α 5β 1, α 8β 1, α Vβ 1, α Vβ 3, α Vβ 5, α Vβ 6, α Vβ 8, and α IIbβ 3) share the ability to recognize ligands containing an RGD tripeptide active site. We also clarified the involvement of integrin α 5β 1 in dopaminergic neurite outgrowth to the striatal cell region using specific pharmacological inhibitors. The dopaminergic neurites preferred to extend on a fibronectin matrix. These results suggest that integrin α 5β 1 expression on dopaminergic neurons plays an important role in dopaminergic neurite outgrowth to the striatal cell region. However, the involvement of other integrins cannot be excluded because dopaminergic neurites also showed extension on a collagen matrix. In accordance with a previous report in which integrin α 5 and β 1 mRNAs were expressed in the substantia nigra and the ventral tegmental area 26 , we confirmed integrin α 5β 1 mRNA expression in mesencephalic cultures and detected the expression of the corresponding proteins on almost all dopaminergic neurons. Our previous study 10 reports that the percentage of dopaminergic neurons that express G-protein-activated inwardly rectifying potassium channel (GIRK)-2 and calbindin were 48% and 46%, respectively, in this cultures. Although mesencephalic dopaminergic neurons could be divided into three distinct nuclei such as A8, A9 and A10 27 , expression of integrin α 5β 1 on dopaminergic neurons seems to be not restricted to GIRK-2-positive A9 cells in the substantia nigra. These findings suggest that integrin α 5β 1 expression on dopaminergic neurons does not necessarily participate in axonal guidance of the nigrostriatal dopaminergic projection.
Importantly, integrin α 5 and β 1 mRNAs were also expressed in striatal cultures. To clarify the involvement of integrin α 5β 1 expression on dopaminergic neurons, we selectively knock downed integrin α 5 in mesencephalic and striatal cultures using a genetic-based approach. Integrin α 5 assembles only with integrin β 1, whereas integrin β 1 assembles with integrin α 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, V 25 . That is why knockdown of integrin α 5 is necessary and sufficient to suppress the function of integrin α 5β 1. Knockdown of integrin α 5 in dopaminergic neurons suppressed neurite outgrowth to the striatal cell region. The knockdown of integrin α 5 in non-dopaminergic mesencephalic and striatal cells had no effect on neurite outgrowth. Therefore, we conclude that integrin α 5β 1 expression on dopaminergic neurons plays an important role in neurite outgrowth to the striatal cell region.
To enhance the dopaminergic neurite outgrowth on striatal neurons, we attempted to overexpress integrin α 5 in dopaminergic neurons. Because of the size of integrin α 5 coding sequence, the lentiviral titer of integrin α 5-expressing vector was much lower than that of control vectors. The difference in viral titers made it difficult to equalize the infection efficiency in dopaminergic neurons of mesencephalic cultures. Therefore, we transduced mouse ES cells to stably express integrin α 5 using lentiviral vectors. The elongation factor-1α (EF-1α ) promoter was reported to be ineffective in TH-positive cells differentiated from ES cells 28 . However, we showed that expression of transgenes under the control of the EF-1α promoter, although reduced, was maintained in dopaminergic neurons derived from ES cells in some clones. However, when integrin α 5-overexpressing ES cells were differentiated with the SDIA method, a large number of TuJ1-negative colonies appeared, thus resulting in a reduction in neural differentiation efficiency. This effect may be due to the promotion of endodermal differentiation of ES cells g and h) The effect of integrin α 5 overexpression on the neurite length of ES cell-derived dopaminergic neurons. ES cell-derived colonies were detached from feeder cells after 13 days of differentiation and then dissociated into single cells. These cells were replated on striatal cultures and then processed for immunostaining after cultivation for the indicated times. Representative images (g) were obtained 2 days after cultivation on striatal cultures. Scale bar = 100 μ m. n = 10-18. **p < 0.01 and ***p < 0.001 vs. LV-control.
Scientific RepoRts | 7:42111 | DOI: 10.1038/srep42111 by integrin α 5β 1 29, 30 . Regardless, we successfully prepared integrin α 5-overexpressing dopaminergic neurons differentiated from ES cells. Furthermore, we showed that overexpression of integrin α 5 enhanced dopaminergic neurite outgrowth on striatal cells. In support of our finding that integrin α 5 plays a role in neurite outgrowth, expression of integrin α 5 in neuron-like cells conferred neurite outgrowth on fibronectin 31 . Myosin light chain kinase can function downstream of integrin activation via extracellular signal-regulated kinase 32 . It is proposed that retrograde actin flow driven by myosin, which is activated by myosin light chain kinase, participates in axonal elongation 33 . The ligands for integrin α 5β 1 expressed on striatal neurons remain unknown. Dopaminergic axons originating from grafts run parallel to the neurites of striatal medium-sized spiny neurons, which are the target cells for dopaminergic innervation 34 . This finding suggests the existence of specific adhesion molecules on striatal neurons for dopaminergic innervation. Recently, it was reported that integrin α 5 is highly expressed in striatal neurons innervated by nigral dopaminergic neurons 35 . However, integrins are known to form heterophilic interactions at cell-cell adhesions. Fibronectin, which is the most recognized ligand for integrin α 5β 1, is mainly produced in astrocytes and fibroblasts 36 . Fibronectin expression is increased by cytokines and injury 37 . Moreover, the L1 cell adhesion molecule, a disintegrin and metalloproteinases-15 and -17 functionally interact with integrin α 5β 1 18, 38, 39 . Especially, L1 is reported to enhance dopaminergic neurite outgrowth in mesencephalic cultures 40 . Further investigations are needed to elucidate the integrin α 5β 1 ligands expressed on striatal neurons.
In summary, we showed that integrin α 5β 1 expression on dopaminergic neurons plays a role in the dopaminergic neurite outgrowth on striatal neurons. The present study aids in the understanding of how axons extend to their target areas during development. In addition, our findings suggest that integrin α 5 overexpression in dopaminergic neurons promote the neurite outgrowth on striatal neurons.
Materials and Methods
Materials. Human GDNF was purchased from Alomone Labs (Jerusalem, Israel). The neural cell adhesion molecule (NCAM) function-blocking antibody (AB5032) was purchased from Merck Millipore (Billerica, MA, USA). RGDS was purchased from Peptide Institute (Osaka, Japan). RGES was purchased from Abbiotec (San Diego, CA, USA). Cyclo(RGDfV) was obtained from ENZO Life Sciences (Farmingdale, NY, USA). ATN-161 (Ac-PHSCN-NH 2 ) and A5-1 (VILVLF) were synthesized by Medical & Biological Laboratories (Nagoya, Japan). The anti-integrin α 5 function-blocking antibody (HMa5-1) was purchased from Santa Cruz (Dallas, TX, USA). The anti-integrin β 1 function-blocking antibody (Ha2/5), fibronectin (human), collagen I (rat), and laminin (mouse) were purchased from Becton-Dickinson (Franklin Lakes, NJ, USA).
Paired-cultivation of mesencephalic cells with striatal cells. Primary ventral mesencephalic and
striatal cells were prepared from rat embryos on the 16th day of gestation. As previously described 10, 41 , mesencephalic cells were adjacently paired-cultured with striatal cells using a water-repellent isolation wall. Briefly, the isolation wall (1.0-mm thick) was placed on a polyethylenimine-coated coverslip in a 35-mm culture dish. The mesencephalic cell suspension (120 μ L) was plated inside the isolation wall (3.0 × 10 5 cells/cm 2 ), and the striatal cell suspension (1.5 mL) was plated outside the isolation wall (3.0 × 10 5 cells/cm 2 ). The isolation wall was removed 24 h after plating. Cultures were maintained in Eagle's minimum essential medium containing 10% fetal calf serum (1-4 days in vitro) or horse serum (5-12 days in vitro). Treatment with drugs was performed after removal of the isolation wall. Primary striatal astrocytes were prepared and enriched from rat embryos on the 16th day of gestation according to previously described procedures 42 . Cultures were incubated at 37 °C in an atmosphere of 5% CO 2 in air with 100% relative humidity. All animals were treated in accordance with the guidelines of the Kyoto University Animal Experimentation Committee and the Japanese Pharmacological Society. This study was approved by Kyoto University Animal Experimentation Committee.
Induction of neural differentiation of mouse embryonic stem (ES) cells. Undifferentiated mouse
ES cells (EB5, kindly provided by Dr. Hitoshi Niwa, RIKEN Center for Developmental Biology; Kobe, Japan) were maintained on gelatin-coated dishes in Glasgow minimum essential medium supplemented with 1% fetal calf serum, 5% knockout serum replacement (Thermo Fisher Scientific, Waltham, MA, USA), 2 mM glutamine, 0.1 mM nonessential amino acids, 1 mM pyruvate, 0.1 mM 2-mercaptoethanol, and 2,000 U/ml leukemia inhibitory factor (Nacalai Tesque, Kyoto, Japan). EB5 cells carry the blasticidin S-resistance gene driven by the Oct3/4 promoter (active in the undifferentiated state) and were maintained in medium containing 20 μ g/ml blasticidin S to eliminate differentiated cells 43, 44 . Dopaminergic neurons were differentiated from mouse ES cells using the SDIA method as previously described 19 . Briefly, ES cells were co-cultured on PA6 stromal cells at a single-cell density in differentiation medium (Glasgow minimum essential medium supplemented with 10% knockout serum replacement, 2 mM glutamine, 0.1 mM nonessential amino acids, 1 mM pyruvate, and 0.1 mM 2-mercaptoethanol). For the replating of ES cell-derived cells on striatal cells, ES cell-derived colonies were detached from PA6 cells after 13 days of differentiation by incubation with collagenase type IV (Sigma-Aldrich, St. Louis, MO, USA) for 3 min at 37 °C. The detached colonies were isolated by spontaneous sedimentation, and gently triturated into single cells in the presence of Dispase (Thermo Fisher Scientific). ES cell-derived cells were replated on striatal cultures in the differentiation medium.
Immunocytochemistry. Immunocytochemistry was performed as previously described 10 . Following fixation with 4% paraformaldehyde, cells were sequentially incubated with 0.2-0.5% Triton X-100, primary antibodies, and secondary antibodies. For diaminobenzidine staining, cells were incubated with the avidin-biotinylated horseradish peroxidase complex (Vector Laboratories, Burlingame, CA, USA) and reacted with a diaminobenzidine solution (Dojindo Laboratories, Kumamoto, Japan). For nuclear staining, cells were incubated with Hoechst 33258 (100 μ g/mL). The following antibodies were commercially obtained: anti-TH from Merck Millipore, Scientific RepoRts | 7:42111 | DOI: 10.1038/srep42111
anti-MAP2 from Sigma-Aldrich, anti-pNF (SMI 31) and anti-neuronal class III β -tubulin (Tuj1) from Covance (Princeton, NJ, USA), anti-GFP from Nacalai Tesque, anti-GFAP from Merck Millipore, anti-integrin α 5 (HMa5-1) and anti-integrin β 1 (N-20) from Santa Cruz. Images of living or immunostained cells were obtained using an IX81 inverted research microscope (Olympus, Tokyo, Japan), a BZ-8100 fluorescence microscope (Keyence, Osaka, Japan), and an A1RMP multiphoton confocal microscope (Nikon, Tokyo, Japan). The fluorescence of immunostained cells was analyzed on a BD FACSAria III cell sorter (Becton-Dickinson).
Measurement of dopaminergic neurite length.
To measure dopaminergic neurite length in the paired-cultures of mesencephalic and striatal cells, cultures were processed for TH immunostaining. As previously described 10 , the borderline of the mesencephalic cell region was defined as the position of the most laterally located TH-positive dopaminergic soma. The distance from TH-positive dopaminergic growth cones to the borderline was measured and defined as the neurite length. The sum of all dopaminergic neurite lengths in a width of 890 μ m was calculated. To produce a continuous image, several photographs were merged using a BZ Analyzer (Keyence). There were four subjects for each experiment.
The measurements of neurite length of ES-derived dopaminergic neurons were completed using Image J software (National Institutes of Health, Bethesda, MD, USA) with the NeuronJ plug-in.
RT-PCR. Total RNA was isolated using a High Pure RNA Isolation Kit (Roche, Basel, Switzerland) according to the manufacturer's instructions. Total RNA was reverse-transcribed using oligo (dT) primers and RT-PCR was performed using a PrimeScript RT-PCR Kit (Takara Bio, Shiga, Japan) according to the manufacturer's instructions. Table 1 Table 1 . Primer sets used in PCR analysis for mRNA expression.
annealing 67 base pair sense and antisense oligos that contained a 19-base stem from the rat integrin α 5 sequence (5′ -CACTAGCCAACCAGGAGTA-3′ ) 45 and a 15-base loop (5′ -ACGTGTGCTGTCCGT-3′ ). Control shRNA contained a non-targeting stem (5′ -ACGTGACACGTTCGGAGAA-3′ ). The annealed oligos were subcloned into pENTER-H1 at the BglII and XbaI sites, and were recombined into CS-RfA-EVBsd using Gateway LR Clonase II (Thermo Fisher Scientific). Mouse integrin α 5 cDNA was amplified by PCR from mouse whole brain cDNA, and the coding region was verified by DNA sequencing. The cDNA was subcloned into CSII-EF-RfA-IRES2-Venus by replacing the RfA Gateway cassette. The vector contains an EF-1α promoter and an internal ribosomal entry site 2 (IRES2) followed by Venus, which is a variant of yellow fluorescent protein 46 . The lentiviral vectors expressing Venus only or integrin α 5 followed by Venus were generated by transient cotransfection of HEK293T cells with CSII-EF-IRES2-Venus or CSII-EF-Itga5-IRES2-Venus, respectively, the packaging construct (pCAG-HIVgp), and the envelop-and Rev-expressing construct (pCMV-VSV-G-RSV-Rev). Two days after transfection, the vector-containing supernatant was collected, filtered through a 0.22-μ m-pore-size filter, and concentrated by centrifugation at 50,000 g for 2 hours at 20 °C. The virus pellet was resuspended in culture medium and stored at − 80 °C until use. For the enhancement of lentiviral infection, polybrene (8 μ g/mL) was added to the lentiviral vector-containing medium.
Western blot analysis. The Western blot analysis was conducted as previously described 47 , except that the detection of integrin α 5 was performed under non-reducing conditions. The following antibodies were commercially obtained: anti-integrin α 5 (AB1928) from Merck Millipore and anti-β -actin (AC-15) from Sigma-Aldrich.
Statistics. The statistical significance of the differences between three or more groups was analyzed with a one-way analysis of variance (ANOVA) followed by post-hoc multiple comparisons using the Turkey's test. Statistical significance was defined as p < 0.05. Data are expressed as the mean ± standard error of the mean (SEM).
